Kazutaka Murayama

12PUBLICATIONS
50CO-AUTHORS
Medical devicesBiologically active moleculesGene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 27, 2026
Preparation of soluble and functional recombinant HTLV-1 Tax protein using bacterial chaperones.

|Jan 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi

|Sep 26, 2024
Absolute quantification of BACH1 and BACH2 transcription factors in B and plasma cells reveals their dynamic changes and unique roles.

Takeshi Kurasawa, Akihiko Muto, Mitsuyo Matsumoto

|Sep 05, 2024
Structural and virologic mechanism of the emergence of resistance to Mpro inhibitors in SARS-CoV-2.

Shin-Ichiro Hattori, Haydar Bulut, Hironori Hayashi

|Feb 09, 2024
Helix-based screening with structure prediction using artificial intelligence has potential for the rapid development of peptide inhibitors targeting class I viral fusion.

Satoshi Suzuki, Mio Kuroda, Keisuke Aoki

|Oct 28, 2022
Structural basis for the substrate specificity switching of lysoplasmalogen-specific phospholipase D from Thermocrispum sp. RD004668.

Hiroaki Hamana, Yoshiaki Yasutake, Miyuki Kato-Murayama

Pageof 2

Frequent Collaborators

3 joint publications

Hironori Hayashi

2 joint publications

Daisuke Sugimori

2 joint publications

Tomomi Kimura-Someya

2 joint publications

Kazuya Hasegawa